Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ELV Elevance Health Inc

395,00

4,27 (1,09%)

Zuletzt aktualisiert: 16:05:35

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Elevance Health (NYSE:ELV)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Elevance Health Charts.

Elevance Health (NYSE:ELV)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Elevance Health Charts.

News Elevance Health Inc

Form 8-K - Current report
Donnerstag 23 Januar 2025 (4 Stunden vor) • Edgar (US Regulatory)

Elevance Health Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Outlook
Donnerstag 23 Januar 2025 (4 Stunden vor) • Business Wire

Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025
Donnerstag 9 Januar 2025 (2 Wochen vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

AM Best Affirms Credit Ratings of Elevance Health, Inc. and Its Subsidiaries
Mittwoch 11 Dezember 2024 (1 Monat vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Elevance Health Announces Appearance at UBS Global Healthcare Conference
Dienstag 5 November 2024 (3 Monate vor) • Business Wire

Elevance Health Appoints Nathan Rich Vice President, Investor Relations
Montag 4 November 2024 (3 Monate vor) • Business Wire

Form 8-K - Current report
Donnerstag 31 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Mittwoch 23 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dienstag 22 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Elevance Health Inc News-Artikel

Health Care Select Sector

Invesco QQQ Trust Series 1

Deutsche Telekom

BNP Paribas (QX)

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen